THOMAS R STAAB II Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for THOMAS R STAAB II.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of THOMAS R STAAB II. THOMAS R STAAB II is a Senior Vice President and CFO in BIOCRYST PHARMACEUTICALS INC ($BCRX) and a Chief Financial Officer in INSPIRE PHARMACEUTICALS INC ($ISPH) and a Chief Financial Officer in LENSAR, Inc. ($LNSR).
Address: C/O INSPIRE PHARMACEUTICALS, INC. 4222 EMPEROR BLVD. / SUITE 200 DURHAM 27703 NC
Companies in which THOMAS R STAAB II is an Insider
BIOCRYST PHARMACEUTICALS INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of THOMAS R STAAB II: Senior Vice President and CFO
Holdings: 134,926 shares
Current Value: $765,030
Latest Transaction: Feb 25 2020
$BCRX Market Capitalization: $427.06M
$BCRX Previous Close: $5.67
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
INSPIRE PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of THOMAS R STAAB II: Chief Financial Officer
Holdings: 0 shares
Latest Transaction: Sep 29 2004
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
LENSAR, Inc.
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of THOMAS R STAAB II: Chief Financial Officer
Holdings: 115,657 shares
Latest Transaction: Apr 14 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of THOMAS R STAAB II
Sentiment: All, BCRX, ISPH, LNSR
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 14 2021 | LNSR | LENSAR, Inc. | STAAB THOMAS R II | Chief Financial Off ... | Option Exercise | A | 6.91 | 49,197 | 339,951 | 49,197 | |
| Dec 10 2020 | LNSR | LENSAR, Inc. | STAAB THOMAS R II | Chief Financial Off ... | Grant | A | 0.00 | 19,276 | 0 | 115,657 | 96.4 K to 115.7 K (+20.00 %) |
| Feb 25 2020 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | A | 11.13 | 18,000 | 200,340 | 18,000 | |
| Feb 19 2020 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | A | 11.13 | 31,500 | 350,595 | 31,500 | |
| Dec 19 2019 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | A | 3.23 | 165,000 | 532,950 | 165,000 | |
| May 20 2019 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 1.42 | 4,750 | 6,745 | 61,000 | |
| May 20 2019 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 7.45 | 2,500 | 18,625 | 125,176 | 127.7 K to 125.2 K (-1.96 %) |